Advertisement
UK markets close in 3 hours 30 minutes
  • FTSE 100

    8,095.50
    +55.12 (+0.69%)
     
  • FTSE 250

    19,716.47
    -2.90 (-0.01%)
     
  • AIM

    755.23
    +0.54 (+0.07%)
     
  • GBP/EUR

    1.1671
    +0.0026 (+0.22%)
     
  • GBP/USD

    1.2512
    +0.0049 (+0.40%)
     
  • Bitcoin GBP

    51,039.10
    -2,176.80 (-4.09%)
     
  • CMC Crypto 200

    1,358.12
    -24.45 (-1.77%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.95
    +0.14 (+0.17%)
     
  • GOLD FUTURES

    2,341.60
    +3.20 (+0.14%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,968.74
    -119.96 (-0.66%)
     
  • CAC 40

    8,014.67
    -77.19 (-0.95%)
     

Why Biogen Stock Popped as Much as 37.1% This Week

Why Biogen Stock Popped as Much as 37.1% This Week

Shares of Biogen (NASDAQ: BIIB) shot up as much as 37.1% this week, according to data from S&P Global Market Intelligence. The large-cap drugmaker with a market cap of $39 billion announced that its new Alzheimer's drug it developed in a partnership with Eisai showed tremendous promise in a clinical trial. As of 12:42 p.m. ET on Friday, shares of Biogen were up 35.5% this week.